Sharing our research
We are committed to sharing our research findings in order to further medical advances and innovation, and meet patient needs.
Our clinical trial results are made public, regardless of whether they reflect positively or negatively on our medicines, because we believe this is fundamental to the advancement of medical science. It is also the best way to tell healthcare professionals and patients about scientific findings relating to our medicines.
In recent years, we have taken a number of steps to be more transparent around these results, and have placed a focus on forming research collaborations with others. In doing so, we can advance our understanding of medicines and over-the-counter healthcare products for the benefit of New Zealanders and others around the world.
As well as reporting the end results of clinical studies, we are being more open with our expertise, know-how and intellectual property around research, particularly into neglected tropical diseases.
The Register is a resource for researchers, medical professionals and the public to access data from GSK-sponsored clinical studies. Visit our global website for more information and access to our Clinical Study Register.
Our online system for researchers to request access to anonymised patient-level data sitting behind the results of clinical trials. This system will allow researchers to examine the study details more closely, do their own analyses and learn more about medicines and how they can best be used.
Our open innovation strategy is designed to promote change beyond GSK by sharing expertise, resources intellectual property and know-how with external researchers and the scientific community.